查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1955319

2026年全球酵素市场报告

Enzymes Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，酵素市场发展迅速，预计将从2025年的152亿美元成长到2026年的172.9亿美元，复合年增长率达13.7%。过去几年的成长可归因于对治疗性酵素的需求不断增长、微生物发酵技术的进步、生物技术领域研究的进展、基于酶的诊断方法的应用以及製药生产的扩张。

预计未来几年酵素市场将快速成长，到2030年市场规模将达287亿美元，复合年增长率（CAGR）为13.5%。预测期内的成长将主要得益于个人化医疗的进步、蛋白质工程的进步、食品饮料行业对工业酶需求的增长、对永续酶生产的日益重视以及亚太新兴市场的扩张。预测期内的关键趋势包括酵素工程和蛋白质设计、工业酵素应用范围的扩大、个性化酵素疗法、微生物酵素的创新以及环境永续的酵素生产。

未来几年，需要使用药物代谢酶（DME）进行化疗的癌症患者数量不断增加，预计将推动酵素市场成长。酵素在癌细胞的破坏和肿瘤的降解中发挥关键作用。 DME在癌症患者肿瘤组织和代谢器官中的表现和功能至关重要，尤其是在抗癌药物和化疗反应有限的患者中。例如，美国癌症协会（总部位于美国的专业组织）在2025年9月估计，2025年美国将新增313,780例前列腺癌病例。摄护腺癌的发生风险随年龄增加而急遽上升，70-79岁男性的发生率高达6.5%，而50岁以下男性的发生率仅为0.2%。因此，可使用治疗性酵素治疗的癌症病例的不断增加预计将推动酵素市场的成长。

为了提供患者更好的治疗方案，酵素製剂市场的主要企业正在开发创新治疗方法，例如 Ramzade（velmanase alfa）。 Ramzade 用于治疗 α-甘露糖苷酶甘露醣储积症，这是一种罕见的遗传性疾病，由溶酶体 α-半乳糖苷酶 A 的活性不足引起。 2023 年 5 月，总部位于美国的製药公司 Chase Global Rare Diseases, Inc. 的 Ramzade 获得 FDA核准，用于治疗轻度至中度 α-甘露醣储积症缺乏症患者的非神经系统症状。 Ramzade 是一种重组人类 α-甘露糖苷酶，采用重组 DNA 技术在中国仓鼠卵巢(CHO) 细胞中生产，是美国首个核准用于治疗该疾病非中枢神经系统症状的酵素替代疗法。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球酵素市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术和循环经济
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 酵素工程和蛋白质设计
    • 扩大工业酵素的应用
    • 个性化酵素疗法
    • 微生物酵素的创新
    • 环境友善永续的酵素生产

第五章 终端用户产业市场分析

  • 製药公司
  • 医院
  • 私人诊所
  • 研究所
  • 生物製药公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球酵素市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球酵素市场规模、对比及成长率分析
  • 全球酵素市场表现：规模与成长，2020-2025年
  • 全球酵素市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 依产品类型
  • Asparaginase、脂肪酶、蛋白酶、纳豆激酶、几丁质酶、锯齿肽酶、胶原酶、连接酶及其他产品
  • 透过使用
  • 白血病、胃肠道疾病、抗肿瘤、皮肤溃疡、高雪氏症、法布瑞氏症及其他适应症
  • 最终用户
  • 药厂、医院、私人诊所、研究机构
  • 依类型细分：Asparaginase
  • L-天Asparaginase、欧文氏菌天冬Asparaginase、聚乙二醇化天Asparaginase
  • 依类型细分：脂肪酶
  • 胃脂肪酶、胰脂肪酶、真菌脂肪酶、细菌脂肪酶
  • 按类型细分：蛋白酶
  • 丝胺酸蛋白酶、半胱氨酸蛋白酶、天门冬胺酸蛋白酶、金属蛋白酶
  • 依类型细分：那曲唑酶
  • 纳曲酮粉剂、纳曲酮胶囊
  • 按类型细分：几丁质酶
  • 植物几丁质酶，微生物几丁质酶
  • 按类型进行亚片段化：锯齿肽酶
  • 沙雷肽酶片，沙雷肽酶胶囊
  • 依类型细分：胶原蛋白酶
  • I型胶原蛋白、II型胶原蛋白、III型胶原蛋白
  • 按类型细分：连接酶
  • DNA连接酶，RNA连接酶
  • 按类型细分：其他产品
  • 淀粉酶、纤维素酶、β-葡聚醣酶

第十章 区域与国家分析

  • 全球酵素市场：依地区划分，结果及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球酵素市场：依国家、表现和预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 酵素市场：竞争格局及市场占有率（2024年）
  • 酵素市场：公司估值矩阵
  • 酵素市场：公司概况
    • Novozymes A/S
    • DuPont Industrial Biosciences
    • BASF SE
    • Koninklijke DSM NV
    • Chr. Hansen Holding A/S

第37章：其他领先和创新企业

  • Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年酵素市场展望：蕴藏新机会的国家
  • 2030年酵素市场：充满新机会的细分市场
  • 2030年酵素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: PH3MENZY01_G26Q1

Enzymes are proteins that typically act as biological catalysts, accelerating specific chemical reactions within cells. They function as catalysts in living organisms, regulating the speed of chemical processes without undergoing any permanent changes themselves.

The main types of enzymes include asparaginase, lipase, protease, nattokinase, chitinase, serratiopeptidase, collagenase, ligase, and others. Proteases are enzymes that catalyze proteolysis, breaking down proteins into smaller polypeptides or single amino acids and supporting the formation of new protein products. Enzymes are used in the treatment of leukemia, stomach disorders, tumors, skin ulcers, Gaucher disease, Fabry disease, and other conditions, and are employed by drug manufacturers, hospitals, private clinics, and research laboratories.

Tariffs have impacted the enzymes market by increasing the cost of imported raw materials, laboratory equipment, and specialized production machinery. This has slowed the expansion of enzyme manufacturing and research in regions heavily reliant on imports, such as North America and Europe. Segments like industrial enzymes and therapeutic enzymes are most affected due to high import dependency. However, tariffs are also driving local manufacturing initiatives and encouraging investment in domestic enzyme production facilities, potentially reducing future supply chain risks.

The enzymes market research report is one of a series of new reports from The Business Research Company that provides enzymes market statistics, including enzymes industry global market size, regional shares, competitors with a enzymes market share, detailed enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the enzymes industry. This enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enzymes market size has grown rapidly in recent years. It will grow from $15.2 billion in 2025 to $17.29 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to rising demand for therapeutic enzymes, development of microbial fermentation technology, increasing research in biotechnology, adoption of enzyme-based diagnostics, expansion of pharmaceutical manufacturing,.

The enzymes market size is expected to see rapid growth in the next few years. It will grow to $28.7 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to growth in personalized medicine, advances in protein engineering, rising demand for industrial enzymes in food and beverage, increasing focus on sustainable enzyme production, expansion of emerging markets in asia-pacific. Major trends in the forecast period include enzyme engineering and protein design, industrial enzyme applications expansion, personalized enzyme therapy, microbial enzyme innovation, green and sustainable enzyme production.

The growing prevalence of cancer requiring drug-metabolizing enzymes (DMEs) for chemotherapy is expected to drive growth in the enzyme market in the coming years. Enzymes play a key role in destroying cancer cells and breaking down tumors. The expression and function of DMEs in tumor tissues and metabolic organs of cancer patients are crucial, particularly for those with limited response to anticancer drugs and chemotherapy. For example, in September 2025, the American Cancer Society, a US-based professional organization, estimated that 313,780 new cases of prostate cancer will occur in the United States in 2025. The risk of developing prostate cancer rises sharply with age, from 0.2% in men under 50 to 6.5% in men aged 70-79. Therefore, the increasing prevalence of cancers treatable with therapeutic enzymes is expected to fuel growth in the enzyme market.

Leading companies in the enzyme market are developing innovative therapies, such as Lamzede, to better serve patients. Lamzede (velmanase alfa) is used to treat alpha-mannosidosis, a rare genetic disorder caused by deficient lysosomal alpha-galactosidase-A enzyme activity. In May 2023, Chiesi Global Rare Diseases, a US-based pharmaceutical company, received FDA approval for Lamzede to treat non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. Lamzede is a recombinant human alpha-mannosidase produced in Chinese hamster ovary (CHO) cells using recombinant DNA technology and represents the first enzyme replacement therapy approved in the U.S. for non-central nervous system manifestations of the disorder.

In February 2023, AstraZeneca, a US-based pharmaceutical company, acquired CinCor Pharma Inc. for $1.3 billion. The acquisition strengthens AstraZeneca's cardiorenal pipeline by adding CinCor's candidate drug, baxdrostat (CIN-107), an aldosterone synthase inhibitor for lowering blood pressure in treatment-resistant hypertension. CinCor Pharma Inc. is a US-based biotechnology company developing enzyme-based therapeutics.

Major companies operating in the enzymes market are Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.

North America was the largest region in the enzymes market in 2025. The regions covered in the enzymes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enzyme market consists of sales of oxidoreductases, transferases, and hydrolases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzymes Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Other Products
  • 2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Other Applications
  • 3) By End User: Drug Manufacturers; Hospitals; Private Clinics; Research Laboratories
  • Subsegments:
  • 1) By Asparaginase: L-asparaginase; Erwinia Asparaginase; Pegylated Asparaginase
  • 2) By Lipase: Gastric Lipase; Pancreatic Lipase; Fungal Lipase; Bacterial Lipase
  • 3) By Protease: Serine Proteases; Cysteine Proteases; Aspartic Proteases; Metalloproteases
  • 4) By Nattokinase: Nattokinase Powder; Nattokinase Capsules
  • 5) By Chitinase: Plant Chitinase; Microbial Chitinase
  • 6) By Serratiopeptidase: Serratiopeptidase Tablets; Serratiopeptidase Capsules
  • 7) By Collagenase: Type I Collagenase; Type II Collagenase; Type III Collagenase
  • 8) By Ligase: DNA Ligase; RNA Ligase
  • 9) By Other Products: Amylase; Cellulase; Beta-Glucanase
  • Companies Mentioned: Novozymes A/S; DuPont Industrial Biosciences; BASF SE; Koninklijke DSM N.V.; Chr. Hansen Holding A/S; Roche Holding AG; Advanced Enzyme Technologies Ltd.; AB Enzymes GmbH; Codexis Inc.; Dyadic International Inc.; Amano Enzyme Inc.; Adisseo France SAS; Biocatalysts Ltd.; Amano Enzyme Inc.; Enzyme Development Corporation; Creative Enzymes; Hayashibara Co. Ltd.; Thermo Fisher Scientific Inc.; Associated British Foods Plc; Lonza Group AG; Novus International Inc.; Epygen Biotech; DSM Nutritional Products AG; Soufflet Biotechnologies SAS; Beijing Leili Marine Bioindustry Inc.; Jiangsu Boli Bioproducts Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Enzymes Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Enzymes Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Enzymes Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Enzymes Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Enzyme Engineering And Protein Design
    • 4.2.2 Industrial Enzyme Applications Expansion
    • 4.2.3 Personalized Enzyme Therapy
    • 4.2.4 Microbial Enzyme Innovation
    • 4.2.5 Green And Sustainable Enzyme Production

5. Enzymes Market Analysis Of End Use Industries

  • 5.1 Drug Manufacturers
  • 5.2 Hospitals
  • 5.3 Private Clinics
  • 5.4 Research Laboratories
  • 5.5 Biopharmaceutical Companies

6. Enzymes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Enzymes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Enzymes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Enzymes Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Enzymes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Enzymes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Enzymes Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Enzymes Market Segmentation

  • 9.1. Global Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products
  • 9.2. Global Enzymes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications
  • 9.3. Global Enzymes Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories
  • 9.4. Global Enzymes Market, Sub-Segmentation Of Asparaginase, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase
  • 9.5. Global Enzymes Market, Sub-Segmentation Of Lipase, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase
  • 9.6. Global Enzymes Market, Sub-Segmentation Of Protease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases
  • 9.7. Global Enzymes Market, Sub-Segmentation Of Nattokinase, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nattokinase Powder, Nattokinase Capsules
  • 9.8. Global Enzymes Market, Sub-Segmentation Of Chitinase, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plant Chitinase, Microbial Chitinase
  • 9.9. Global Enzymes Market, Sub-Segmentation Of Serratiopeptidase, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serratiopeptidase Tablets, Serratiopeptidase Capsules
  • 9.10. Global Enzymes Market, Sub-Segmentation Of Collagenase, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Type I Collagenase, Type II Collagenase, Type III Collagenase
  • 9.11. Global Enzymes Market, Sub-Segmentation Of Ligase, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • DNA Ligase, RNA Ligase
  • 9.12. Global Enzymes Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Amylase, Cellulase, Beta-Glucanase

10. Enzymes Market Regional And Country Analysis

  • 10.1. Global Enzymes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Enzymes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Enzymes Market

  • 11.1. Asia-Pacific Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Enzymes Market

  • 12.1. China Enzymes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Enzymes Market

  • 13.1. India Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Enzymes Market

  • 14.1. Japan Enzymes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Enzymes Market

  • 15.1. Australia Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Enzymes Market

  • 16.1. Indonesia Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Enzymes Market

  • 17.1. South Korea Enzymes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Enzymes Market

  • 18.1. Taiwan Enzymes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Enzymes Market

  • 19.1. South East Asia Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Enzymes Market

  • 20.1. Western Europe Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Enzymes Market

  • 21.1. UK Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Enzymes Market

  • 22.1. Germany Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Enzymes Market

  • 23.1. France Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Enzymes Market

  • 24.1. Italy Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Enzymes Market

  • 25.1. Spain Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Enzymes Market

  • 26.1. Eastern Europe Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Enzymes Market

  • 27.1. Russia Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Enzymes Market

  • 28.1. North America Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Enzymes Market

  • 29.1. USA Enzymes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Enzymes Market

  • 30.1. Canada Enzymes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Enzymes Market

  • 31.1. South America Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Enzymes Market

  • 32.1. Brazil Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Enzymes Market

  • 33.1. Middle East Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Enzymes Market

  • 34.1. Africa Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Enzymes Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Enzymes Market Regulatory and Investment Landscape

36. Enzymes Market Competitive Landscape And Company Profiles

  • 36.1. Enzymes Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Enzymes Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Enzymes Market Company Profiles
    • 36.3.1. Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. DuPont Industrial Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke DSM N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Chr. Hansen Holding A/S Overview, Products and Services, Strategy and Financial Analysis

37. Enzymes Market Other Major And Innovative Companies

  • Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc.

38. Global Enzymes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Enzymes Market

40. Enzymes Market High Potential Countries, Segments and Strategies

  • 40.1 Enzymes Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Enzymes Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Enzymes Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer